Roundhill ETF Trust - Roundhill GLP-1 & Weight Loss ETF (Nasdaq:OZEM) - Stock Price, News & Analysis

OZEM Stock Overview

An exchange traded fund launched and managed by Roundhill Financial Inc.

OZEM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Roundhill ETF Trust - Roundhill GLP-1 & Weight Loss ETF Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Roundhill ETF Trust - Roundhill GLP-1 & Weight Loss ETF
Historical stock prices
Current Share Price	US$28.63
52 Week High	US$28.98
52 Week Low	US$24.51
Beta	0
11 Month Change	7.35%
3 Month Change	14.61%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	12.85%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	OZEM	US Capital Markets	US Market
7D	-0.07%	1.7%	0.3%
1Y	n/a	31.5%	22.2%

Return vs Industry: Insufficient data to determine how OZEM performed against the US Capital Markets industry.

Return vs Market: Insufficient data to determine how OZEM performed against the US Market.

Price Volatility

Is OZEM's price volatile compared to industry and market?
OZEM volatility
OZEM Average Weekly Movement	3.1%
Capital Markets Industry Average Movement	4.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: OZEM has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine OZEM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2024	n/a	n/a	www.roundhillinvestments.com/etf/ozem

Roundhill ETF Trust - Roundhill GLP-1 & Weight Loss ETF is an exchange traded fund launched and managed by Roundhill Financial Inc. The fund is co-managed by Exchange Traded Concepts, LLC. It invests in public equity markets. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, pharmaceuticals, pharmaceutical drugs designed for weight loss and anti-obesity, GLP-1 receptor agonists and GLP-1 & weight loss sectors.

Roundhill ETF Trust - Roundhill GLP-1 & Weight Loss ETF Fundamentals Summary

How do Roundhill ETF Trust - Roundhill GLP-1 & Weight Loss ETF's earnings and revenue compare to its market cap?
OZEM fundamental statistics
Market cap	US$46.99m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is OZEM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OZEM income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did OZEM perform over the long term?

See historical performance and comparison